Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis

Fetal and Pediatric Pathology

Volumn 34, Issue 6, 2015, Pages 341-350

  Li, Ping ^a   Pang, Li Hong ^a   Liang, Hai Feng ^a   Chen, Hong Yan ^a   Fan, Xiao Jing ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

ABO antibody titer; ABO hemolytic disease of the newborn; ABO incompatibility

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; IMMUNOGLOBULIN G; BLOOD GROUP ABO SYSTEM;

ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; FEMALE; HUMAN; META ANALYSIS; NEWBORN DISEASE; NEWBORN SCREENING; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY ANALYSIS; BLOOD; BLOOD GROUP ABO SYSTEM; IMMUNOLOGY; MOTHER; NEWBORN; NEWBORN HEMOLYTIC DISEASE;

ABO BLOOD-GROUP SYSTEM; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; MOTHERS; RISK FACTORS;

EID: 84949111305     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513815.2015.1075632     Document Type: Article

References (32)

1. Gessoni G, Valverde S, Giacomini A, et al. Foetal-maternal alloimmunizations in the South-East area of the Venice province. Minerva Ginecol 2002; 54: 333-338.
2. Bhat YR, Kumar CG. Morbidity of ABO haemolytic disease in the newborn. Paediatr Int Child Health 2012; 32: 93-96.
3. Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007; 92: F83-88.
4. Wan MR. Serum ABO immune antibodies in 1944 pregnant women. Zhonghua Fu Chan Ke Za Zhi 1991; 26: 12-1.
5. Wu Q, Zhang Y, Liu M, et al. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG antibody subclasses in hemolytic disease of newborn. Neonatology 2009; 96: 1-5.
6. Bennardello F, Curciarello G. Survey on the prevention and incidence of haemolytic disease of the newborn in Italy. Blood Transfus 2013; 11: 518-527.
7. Wang M, Hays T, Ambruso DR, et al. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother. Pediatr Blood Cancer 2005; 45: 861-862.
8. Ziprin JH, Payne E, Hamidi L, et al. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia. Transfus Med 2005; 15: 57-60.
9. Curtis BR, Fick A, Lochowicz AJ, et al. Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B. Transfusion 2008; 48: 358-364.
10. Kato S, Sugiura T, Ueda H, et al. Massive intracranial hemorrhage caused by neonatal alloimmune thrombocytopenia associated with anti-group Aantibody. J Perinatol 2013; 33: 79-82.
11. Weng YH1, Chiu YW. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility. Chang Gung Med J 2009; 32: 400-408.
12. Kalakheti BK, Singh R, Bhatta NK, Karki A, Baral N. Risk of neonatal hyperbilirubinemia in babies born to O positive mothers: A prospective cohort study. Kathmandu Univ Med J (KUMJ) 2009; 7: 11-15.
13. Hassanzadeh-Nazarabadi M, Shekouhi S, Seif N. The incidence of spontaneous abortion in mothers with blood group O compared with other blood types. Int J Mol Cell Med 2012; 1: 99-104.
14. Chen JY, Ling UP. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Zhonghua Yi Xue Za Zhi (Taipei) 1994; 53: 13-18.
15. Owa JA, Durosinmi MA, Alabi AO. Determinants of severity of neonatal hyperbilirubinaemia in ABO incompatibility in Nigeria. Trop Doct 1991; 21: 19-22.
16. Egil B, Unni B, Unni B, et al. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate. Acta Paediatr 2009; 98: 1896-1901.
17. Wong KF, Tse KT, Lee AW, et al. Is antenatal antibody screening worthwhile in Chinese? Br J Haematol 1997; 97: 917-919.
18. Kaplan M, Na'amad M, Kenan A, et al. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers. Pediatrics 2009; 123: e132-137.
19. Cariani L, Romano EL, Martinez N, et al. ABO-haemolytic disease of the newborn (ABO-HDN): Factors influencing its severity and incidence in Venezuela. J Trop Pediatr 1995; 41: 14-21.
20. Van Dijk BA, Dooren MC, Overbeeke MA. Red cell antibodies in pregnancy: there is no critical titre. Transfus Med 1995; 5: 199-202.
21. Brouwers HA, Overbeeke MA, van Ertbruggen I, et al. What is the best predictor of the severity of ABO-haemolytic disease of the newborn? Lancet 1988; 2: 641-644.
22. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
24. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005; 28: 123-137.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997; 315: 629-634.
26. Lynen R, Krone O, Legler TJ. A newly developed gel centrifugation test for quantification of RBC-bound IgG antibodies and their subclasses IgG1 and IgG3:comparison with flow cytometry. Transfusion 2002; 42: 612-618.
27. Egil B, Unni B, Unni B, et al. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate. Acta Paediatr 2009; 98: 1896-1901.
28. Yang SM, Wu QY, Luo HQ, et al. Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005; 13: 875-877.
29. Zhu Y-h, Wu W-j, Ma C-h, et al. Relationship between blood group antibody IgG titer of pregnant women and ABO hemolytic disease of newborn in ten provinces and cities in China. Chinese J Biol 2012; 25: 477-479.
30. Akgül S, Korkmaz A, Yiʇit S, Yurdakök M. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter? Turk J Pediatr 2013; 55: 506-509.
31. Sarc SU. ABO incompatibility: which one matters? Turk J Pediatr 2014; 56: 216.
32. Mathai J, Sindhu PN, Sulochana PV, et al. Haemolysin test for characterization of immune ABO antibodies. Indian J Med Res 2003; 118: 125-128.